A study of antithrombotic agent, rivaroxaban, in preventing venous thromboembolism after hip and knee replacement surgery
碩士 === 高雄醫學大學 === 藥學研究所 === 102 === Objectives: Total hip replacement (THR) or total knee replacement (TKR) usually accompanies Venous thromboembolism (VTE). The inci-dence of VTE could be reduced but bleeding increased if preventive an-tithrombotic medicine was used for total joint replacement. Bas...
Main Authors: | Yun-Chuan Mao, 毛雲川 |
---|---|
Other Authors: | Kim-Hong Gan |
Format: | Others |
Language: | zh-TW |
Published: |
2014
|
Online Access: | http://ndltd.ncl.edu.tw/handle/q9t9x6 |
Similar Items
-
Comparative safety and efficacy of antithrombotics in the management of venous thromboembolism after knee or hip replacement surgery: focus on rivaroxaban
by: Kwong LM
Published: (2013-08-01) -
Clinical Effectiveness of Antithrombotic Agents in Preventing Venous Thromboembolism after Total Hip and Total Knee Replacement Surgery
by: Yu-Ying Yu, et al.
Published: (2010) -
Therapeutic potential of rivaroxaban in the prevention of venous thromboembolism following hip and knee replacement surgery: a review of clinical trial data
by: Kwong LM
Published: (2011-07-01) -
Cost-Effectiveness of Rivaroxaban Compared with Enoxaparin for the Prevention of Venous Thromboembolism in Adult Patients Undergoing Elective Hip or Knee Replacement Surgery in Portugal
by: José Roxo Neves, et al.
Published: (2014-01-01) -
Rivaroxaban in preventing venous thromboembolism after arthroplastic surgery in Taiwan
by: Yun-Chuan Mao, et al.
Published: (2015-10-01)